Linder Jeffrey D, Klapow Joshua C, Linder Sheri D, Wilcox C Mel
Department of Medicine, Division of Gastroenterology and Hepatology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
Am J Gastroenterol. 2003 Aug;98(8):1738-43. doi: 10.1111/j.1572-0241.2003.07597.x.
The efficacy of endoscopic treatment of sphincter of Oddi dysfunction (SOD) with endoscopic sphincterotomy (ES) remains controversial. Although some studies have shown a positive impact on patient symptoms after treatment, these reports have been largely qualitative and evaluated on short-term response. The aim of our study was to quantitatively measure the long-term outcomes of endoscopic therapy in patients with SOD.
Thirty-three patients with suspected SOD underwent selective sphincter of Oddi manometry (SOM) of the biliary and/or pancreatic sphincter. Each patient completed a telephone-based survey measuring symptomatic pain before and after SOM +/- ES. The questioner was blinded to the results of SOM. The patients with normal SOM or SOD but who did not undergo ES served as controls.
Of these 33 patients (27 women, mean age 48.7 yr, range 13-74), 19 (57.5%) were found to have SOD (12 biliary, six pancreatic, one both). The average follow-up was 18.1 months (range 7-34). Of the patients with SOD, 17 (89%) underwent ES. At follow-up of the 19 patients undergoing ES, five were taking narcotics for persistent pain, two were taking antidepressants, and 15 identified the endoscopic therapy as the reason for their relief. Of the 14 controls, seven were taking narcotics, seven were taking antidepressants, and two identified the endoscopy as the reason for their relief; some patients were taking both antidepressants and narcotics.
Patients found to have SOD who undergo ES are more likely to be improved on long-term follow-up when compared with patients with suspected SOD but normal manometry without ES. However, almost uniformly, despite ES, patients continue to have pain, which is consistent with most chronic pain disorders and which suggests a multifactorial cause for the pain.
内镜下括约肌切开术(ES)治疗Oddi括约肌功能障碍(SOD)的疗效仍存在争议。尽管一些研究表明治疗后对患者症状有积极影响,但这些报告大多是定性的,且基于短期反应进行评估。我们研究的目的是定量测量SOD患者内镜治疗的长期结果。
33例疑似SOD患者接受了胆管和/或胰管括约肌的选择性Oddi括约肌测压(SOM)。每位患者完成了一项基于电话的调查,测量SOM +/- ES前后的症状性疼痛。调查者对SOM结果不知情。SOM正常或患有SOD但未接受ES的患者作为对照。
在这33例患者(27例女性,平均年龄48.7岁,范围13 - 74岁)中,19例(57.5%)被发现患有SOD(12例胆管型,6例胰管型,1例两者皆有)。平均随访时间为18.1个月(范围7 - 34个月)。在患有SOD的患者中,17例(89%)接受了ES。在接受ES的19例患者随访时,5例因持续性疼痛服用麻醉剂,2例服用抗抑郁药,15例认为内镜治疗是其症状缓解的原因。在14例对照患者中,7例服用麻醉剂,7例服用抗抑郁药;2例认为内镜检查是其症状缓解的原因;一些患者同时服用抗抑郁药和麻醉剂。
与疑似SOD但测压正常且未接受ES的患者相比,被发现患有SOD且接受ES的患者在长期随访中更有可能得到改善。然而,几乎无一例外,尽管接受了ES,患者仍持续疼痛,这与大多数慢性疼痛疾病一致,提示疼痛存在多因素病因